The activation of DPP-4 in the kidney has an important role in TGF-β signaling, and the progression of renal disease by regulating the microRNA29s levels, and that targeted the inhibition of DPP-4 may prove to be a useful new approach in the management of progressive renal disease, including kidney fibrosis. This evidence concerns the gene TGFB1 and kidney disorder.